Ascendis Pharma A/S announced on April 21, 2026, that it will redeem all $575 million of its 2.25% Convertible Senior Notes on May 6, 2026. The redemption price will be $1,002.19 per $1,000 of principal amount, with a potential conversion to ordinary shares at a conversion rate of 6.0118 shares per $1,000 prior to May 4, 2026.